drugset

drugset / Trial / NCT01281566

A Study of Cisapride in Premature Infants With Feeding Problems

NCT01281566 ↗

Phase 4 Terminated 8 enrolled Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the effectiveness of Cisapride in improving feeding problems in premature newborn infants.

Timeline

Start: 2003-03
Primary completion: —
Completion: 2003-07

Outcome

Outcome not reported

Stopped: “Sponsor request”

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Cisapride	Small molecule	0.2 mg/kg	Other

Indications